Clinical Trial Update: An Open-label Study to Define the Safety, Tolerability and Clinical Activity of Deutetrabenazine (AUstedo) in Adult Study Subjects With DYsTonia [Phase 1, Phase 2]

View source ↗

Summary

An open-label Phase 1/2 study in adults with primary dystonia evaluated the safety, tolerability, and clinical activity of Austedo (deutetrabenazine); the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystonia

Drugs mentioned

• AUSTEDO (deutetrabenazine)

Snippet

Sponsor: University of Pennsylvania | Conditions: Dystonia, Primary | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-06-12